Concepedia

Lorenzo Tarli

LT

Statistics

Publications

6

Citations

1.3K

H-Index

6

Active since

1997

Affiliations

ETH Zurich(Current)

Alleanza Contro il Cancro

École Polytechnique Fédérale de Lausanne

University of Siena

Lorenzo Tarli is an author at ETH Zurich specializing in angiogenesis, therapeutic antibody development, and oncology.

Publications per year

1997–2004

6

Publications

6

Prognostic Significance of the Long Pentraxin PTX3 in Acute Myocardial Infarction

Roberto Latini, Aldo P. Maggioni, Giuseppe Peri et al. · Circulation · 2004 · 429 citations

Medicine, Cardiology, Internal Medicine +17

Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform

Dario Neri, Barbara Carnemolla, Ahuva Nissim et al. · Nature Biotechnology · 1997 · 282 citations

Pharmacy, Molecular Biology, Molecular Pharmaceutics +16

A High-Affinity Human Antibody That Targets Tumoral Blood Vessels

Lorenzo Tarli, Enrica Balza, Francesca Viti et al. · Blood · 1999 · 209 citations

Pharmacy, Immunology, Oncology +14

Increased binding affinity and valence of recombinant antibody fragments lead to improved targeting of tumoral angiogenesis.

Francesca Viti, Lorenzo Tarli, Leonardo Giovannoni et al. · PubMed · 1999 · 208 citations

Medicine, Cancer Biology, Oncology +17

Selective targeting of tumour neovasculature by a radiohalogenated human antibody fragment specific for the ED-B domain of fibronectin

Salvatore Demartis, Lorenzo Tarli, Laura Borsi et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2001 · 90 citations

Medicine, Cancer Biology, Oncology +17

1–5 of 6